VentriPoint Diagnostics Ltd. (TSXV:VPT) Interview with Ted Ohashi and Ticker Talk

Ted Ohashi, CFA, Consultant - Video Host

Ted Ohashi, host of InvestmentPitch.com's Ticker Talk and Interview Series explains the advantage of utilizing InvestmentPitch.com's interviewing process.

MERUS LABS INTERNATIONAL INC. - CNSX: MR - News Update

MERUS LABS INTERNATIONAL INC. ANNOUNCES LISTING WITH THE CANADIAN NATIONAL STOCK EXCHANGE

Established in 2003, Gemoscan owns and markets the Hemocode System, a well-being and lifestyle solution that with a simple, patented blood test detects and provides solutions for food intolerances. The Hemocode System generates customer-specific charts, reports and recipe books which are provided to the customer accompanied by feedback from a health care specialist.

Premier Diagnostic Health Services Inc (CNSX: PDH) Our business is advanced molecular imaging that provides physicians and healthcare professionals with the early and accurate detection of cancer and other diseases. Our core technology is state-of-the-art PET-CT scanning, the gold standard in diagnostic imaging.

Abattis Biologix is a specialty biotechnology company engaged in the development, licensing, sale and distribution of botanical-based antiviral products. At present, the Company is focused on refining and bringing to market a proprietary nutraceutical formulation of botanical agents with demonstrated ability to inhibit the growth of, and reduce the severity and duration of various strains of human influenza and other viral diseases. Continuing research is being conducted at the Institute for Antiviral Research, Utah State University.

Investment firm Canaccord Genuity, has initiated coverage on Exact Sciences, which trades on NASDAQ, under the symbol “EXAS”